Skip to main content

European Immunogenicity Platform

Main navigation

Home
EIP
- About EIP
- Members
- Board
- Join EIP
Symposium
- Overview
- Program
Publications
- EIP Publications
- Regulatory Guidelines
Presentations
Contact us

Home

MEA Guideline CHMP/BMWP/14327/2006 – 01/05/2008

EMEA Guideline CHMP/BMWP/14327/2006 – 01/05/2008
Guideline on immunogenicity assessment of biotechnology-derived therapeutic proteins

Lisbon 1

Lisbon 2

Lisbon 3

Lisbon 4

Lisbon 5

Lisbon 6

Lisbon 7

Lisbon 8

© Copyright 2020

Preferences

Please adapt your cookies preferences.

Operational

Operational cookies ensure the smooth running of the site and cannot be disabled.

Optimized

The cookies optimization allows us to analyze the use of the site in order to improve it.

Example of permitted functionalities

Memorization of the favorite language
Session cookies storage
Anonymous follow up via google Analytics
Follow up at marketing ends

Example of operational not allowed

Registration of the users’ personal data

Example of permitted functionalities

Memorization of the favorite language
Session cookies storage

Example of operational not allowed

Anonymous follow up via google Analytics
Follow up at marketing ends
Registration of the users’ personal data

For more information, please read our cookies policy

The use of cookies on our website requires your consent.